[DPHARMA] YoY Cumulative Quarter Result on 30-Jun-2012 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
16-Aug-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
30-Jun-2012 [#2]
Profit Trend
QoQ- 102.37%
YoY- 5.59%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Revenue 101,907 81,118 75,826 70,412 68,329 64,777 61,728 8.71%
PBT 20,605 21,302 21,963 17,906 17,166 16,582 20,337 0.21%
Tax -5,788 -5,410 -4,575 -4,331 -4,310 -4,146 -4,877 2.89%
NP 14,817 15,892 17,388 13,575 12,856 12,436 15,460 -0.70%
-
NP to SH 14,817 15,892 17,388 13,575 12,856 12,436 15,460 -0.70%
-
Tax Rate 28.09% 25.40% 20.83% 24.19% 25.11% 25.00% 23.98% -
Total Cost 87,090 65,226 58,438 56,837 55,473 52,341 46,268 11.11%
-
Net Worth 190,284 179,045 187,340 162,400 154,105 140,182 136,003 5.75%
Dividend
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Div 5,596 5,551 5,550 4,858 4,859 6,245 83 101.67%
Div Payout % 37.77% 34.93% 31.92% 35.79% 37.80% 50.22% 0.54% -
Equity
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Net Worth 190,284 179,045 187,340 162,400 154,105 140,182 136,003 5.75%
NOSH 139,915 138,794 138,770 138,803 138,833 138,794 138,779 0.13%
Ratio Analysis
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
NP Margin 14.54% 19.59% 22.93% 19.28% 18.81% 19.20% 25.05% -
ROE 7.79% 8.88% 9.28% 8.36% 8.34% 8.87% 11.37% -
Per Share
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
RPS 72.83 58.44 54.64 50.73 49.22 46.67 44.48 8.56%
EPS 10.59 11.45 12.53 9.78 9.26 8.96 11.14 -0.83%
DPS 4.00 4.00 4.00 3.50 3.50 4.50 0.06 101.30%
NAPS 1.36 1.29 1.35 1.17 1.11 1.01 0.98 5.61%
Adjusted Per Share Value based on latest NOSH - 138,727
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
RPS 10.59 8.43 7.88 7.32 7.10 6.73 6.42 8.69%
EPS 1.54 1.65 1.81 1.41 1.34 1.29 1.61 -0.73%
DPS 0.58 0.58 0.58 0.51 0.51 0.65 0.01 96.68%
NAPS 0.1978 0.1861 0.1948 0.1688 0.1602 0.1457 0.1414 5.75%
Price Multiplier on Financial Quarter End Date
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Date 30/06/15 30/06/14 28/06/13 29/06/12 30/06/11 30/06/10 30/06/09 -
Price 2.65 2.97 2.38 2.23 2.34 2.45 2.13 -
P/RPS 3.64 5.08 4.36 4.40 4.75 5.25 4.79 -4.47%
P/EPS 25.02 25.94 18.99 22.80 25.27 27.34 19.12 4.58%
EY 4.00 3.86 5.26 4.39 3.96 3.66 5.23 -4.36%
DY 1.51 1.35 1.68 1.57 1.50 1.84 0.03 92.09%
P/NAPS 1.95 2.30 1.76 1.91 2.11 2.43 2.17 -1.76%
Price Multiplier on Announcement Date
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Date 25/08/15 26/08/14 28/08/13 16/08/12 18/08/11 24/08/10 26/08/09 -
Price 2.40 3.37 2.44 2.38 2.22 2.45 2.50 -
P/RPS 3.30 5.77 4.47 4.69 4.51 5.25 5.62 -8.48%
P/EPS 22.66 29.43 19.47 24.34 23.97 27.34 22.44 0.16%
EY 4.41 3.40 5.14 4.11 4.17 3.66 4.46 -0.18%
DY 1.67 1.19 1.64 1.47 1.58 1.84 0.02 108.99%
P/NAPS 1.76 2.61 1.81 2.03 2.00 2.43 2.55 -5.98%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment